A phenylalanine (Phe)-restricted diet is the mainstay of phenylketonuria (PKU) treatment, and, in recent years, the nutritional management of PKU has become more complex in order to optimize patients' growth, development and diet compliance. Dietary restriction of Phe creates a diet similar to a vegan diet, and many of the nutritional concerns and questions applicable to vegans who wish to avoid animal products are also relevant to patients with PKU. Owing to their nutritional characteristics, breast milk and breastfeeding should be given greater consideration as a useful food in patients with PKU and in those with other inborn errors of metabolism. Further key issues for consideration include the quality of the available amino acid substitutes, the neurotrophic and neuroprotective effects of added long-chain polyunsaturated fatty acids (e.g. docosahexaenoic acid), micronutrient deficiencies, bone disease and antioxidant status. Long-term dietary guidance and monitoring of the nutritional status of patients with PKU should be part of a follow-up programme that continues for life.

Nutritional issues in treating phenylketonuria / F. Feillet, C.V. Agostoni. - In: JOURNAL OF INHERITED METABOLIC DISEASE. - ISSN 0141-8955. - 33:6(2010), pp. 659-664.

Nutritional issues in treating phenylketonuria

C.V. Agostoni
Ultimo
2010

Abstract

A phenylalanine (Phe)-restricted diet is the mainstay of phenylketonuria (PKU) treatment, and, in recent years, the nutritional management of PKU has become more complex in order to optimize patients' growth, development and diet compliance. Dietary restriction of Phe creates a diet similar to a vegan diet, and many of the nutritional concerns and questions applicable to vegans who wish to avoid animal products are also relevant to patients with PKU. Owing to their nutritional characteristics, breast milk and breastfeeding should be given greater consideration as a useful food in patients with PKU and in those with other inborn errors of metabolism. Further key issues for consideration include the quality of the available amino acid substitutes, the neurotrophic and neuroprotective effects of added long-chain polyunsaturated fatty acids (e.g. docosahexaenoic acid), micronutrient deficiencies, bone disease and antioxidant status. Long-term dietary guidance and monitoring of the nutritional status of patients with PKU should be part of a follow-up programme that continues for life.
English
Settore MED/38 - Pediatria Generale e Specialistica
Articolo
Esperti anonimi
2010
MTP Press
33
6
659
664
Periodico con rilevanza internazionale
info:eu-repo/semantics/article
Nutritional issues in treating phenylketonuria / F. Feillet, C.V. Agostoni. - In: JOURNAL OF INHERITED METABOLIC DISEASE. - ISSN 0141-8955. - 33:6(2010), pp. 659-664.
none
Prodotti della ricerca::01 - Articolo su periodico
2
262
Article (author)
si
F. Feillet, C.V. Agostoni
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/153981
Citazioni
  • ???jsp.display-item.citation.pmc??? 18
  • Scopus 59
  • ???jsp.display-item.citation.isi??? 50
social impact